116 related articles for article (PubMed ID: 7507946)
1. p53 protein in aggressive and non-aggressive basal cell carcinoma.
De Rosa G; Staibano S; Barra E; Donofrio V; Salvatore G; Vessecchia G; Boscaino A
J Cutan Pathol; 1993 Oct; 20(5):429-34. PubMed ID: 7507946
[TBL] [Abstract][Full Text] [Related]
2. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
[TBL] [Abstract][Full Text] [Related]
3. P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region.
Staibano S; Lo Muzio L; Pannone G; Somma P; Farronato G; Franco R; Bambini F; Serpico R; De Rosa G
Int J Oncol; 2001 Sep; 19(3):551-9. PubMed ID: 11494035
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin.
Staibano S; Boscaino A; Salvatore G; Orabona P; Palombini L; De Rosa G
Hum Pathol; 1996 Jul; 27(7):695-700. PubMed ID: 8698314
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of p53 and COX-2 in basal cell carcinoma.
Enache AO; Stepan AE; Mărgăritescu C; Pătraşcu V; Ciurea RN; Simionescu CE; Camen A
Rom J Morphol Embryol; 2018; 59(4):1115-1120. PubMed ID: 30845292
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
9. Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas.
Demirkan NC; Colakoglu N; Düzcan E
Pathol Oncol Res; 2000; 6(4):272-4. PubMed ID: 11173659
[TBL] [Abstract][Full Text] [Related]
10. Sun-exposure- and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer.
Liang SB; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Chen BK; Sonobe H
Virchows Arch; 1999 Mar; 434(3):193-9. PubMed ID: 10190297
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
12. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
13. Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients.
Cho S; Hahm JH; Hong YS
Br J Dermatol; 2001 Apr; 144(4):841-8. PubMed ID: 11298546
[TBL] [Abstract][Full Text] [Related]
14. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma.
Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC
Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of apoptotic index in cutaneous basal cell carcinomas of head and neck.
Staibano S; Lo Muzio L; Mezza E; Argenziano G; Tornillo L; Pannone G; De Rosa G
Oral Oncol; 1999 Nov; 35(6):541-7. PubMed ID: 10705087
[TBL] [Abstract][Full Text] [Related]
17. The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma.
Bäckvall H; Wolf O; Hermelin H; Weitzberg E; Pontén F
Br J Dermatol; 2004 Feb; 150(2):259-66. PubMed ID: 14996096
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
19. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
